Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aptorum Group Ltd

1.80
+0.09005.26%
Post-market: 1.79-0.0100-0.56%17:54 EDT
Volume:189.81K
Turnover:330.53K
Market Cap:12.86M
PE:-2.30
High:1.81
Open:1.68
Low:1.68
Close:1.71
52wk High:7.49
52wk Low:0.4600
Shares:7.14M
Float Shares:3.40M
Volume Ratio:0.59
T/O Rate:5.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7826
EPS(LYR):-0.7826
ROE:-30.62%
ROA:-8.33%
PB:0.61
PE(LYR):-2.30

Loading ...

Aptorum Group and DiamiR Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference

GlobeNewswire
·
Sep 05

InPost Partners with Bloq.it to Deploy 20,000 Smart Parcel Lockers

Deep News
·
Sep 03

Top Premarket Decliners

MT Newswires Live
·
Aug 22

Top Midday Gainers

MT Newswires Live
·
Aug 22

Diamir Biosciences and Aptorum Group Announce New York State Approval for Diamir’s Apoe Genotyping Test

THOMSON REUTERS
·
Aug 21

DiamiR Biosciences and Aptorum Group Ltd. Secure New York State Approval for APOE Genotyping Test

Reuters
·
Aug 21

Half-Yearly Results

GlobeNewswire
·
Aug 06

Aptorum Group Ltd. Regains Compliance with Nasdaq's Minimum Bid Price Requirement

Reuters
·
Aug 04

Aptorum Group Limited Regains Compliance With Nasdaq’s Minimum Bid Price Requirement

THOMSON REUTERS
·
Aug 04

Press Release: UBS reports 2Q25 net profit of USD 2.4bn and USD 4.1bn for 1H25 with integration remaining on track; invested assets reach USD 6.6trn (Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules)

Dow Jones
·
Jul 30

Aptorum Group Ltd. and DiamiR Biosciences Announce Definitive Agreement for Merger, Aiming to Advance Brain Health Solutions

Reuters
·
Jul 23

BRIEF-Aptorum Group Limited And DiamiR Biosciences Enter Into Definitive Merger Agreement

Reuters
·
Jul 16

Aptorum Group Ltd. Merges with DiamiR Biosciences to Advance Brain Health Solutions

Reuters
·
Jul 16

Q1 Trading Statement for the three months ended 30 June 2025

GlobeNewswire
·
Jul 16

Press Release: SES: Q1 2025 Results

Dow Jones
·
Apr 30